Srikanth Deenadayalan

Effect of Additional Oral Semaglutide vs Sitagliptin on Glycated Hemoglobin in Adults With Type 2 Diabetes Uncontrolled With Metformin Alone or With Sulfonylurea

Julio Rosenstock, Andreas L. Birkenfeld, Thalia Marie Blicher et al. · JAMA · 2019 · 398 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial

Juan P. Frías, Srikanth Deenadayalan, Lars Erichsen et al. · The Lancet · 2023 · 297 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Dose-response, efficacy, and safety of oral semaglutide monotherapy in Japanese patients with type 2 diabetes (PIONEER 9): a 52-week, phase 2/3a, randomised, controlled trial

Yuichiro Yamada, Hideki Katagiri, Yoshiyuki Hamamoto et al. · The Lancet Diabetes & Endocrinology · 2020 · 223 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trial

Daisuke Yabe, Jiro Nakamura, Hideaki Kaneto et al. · The Lancet Diabetes & Endocrinology · 2020 · 203 citations

Medicine, Pharmacology, Pharmacotherapy +15

Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec, in Children and Adolescents With Type 1 Diabetes: The onset 7 Trial

Bruce W. Bode, Violeta Iotova, Lori M. Laffel et al. · Diabetes Care · 2019 · 67 citations · Full text

Medicine, Child Health, Pediatrics +17